New drug combo shows promise against hard-to-treat cancers
Disease control
Completed
This early-phase study tested a new drug called CFT1946 in 89 adults with BRAF V600 mutant solid tumors (like melanoma, lung, or colon cancer). The goal was to find safe doses and see if the drug works alone or with other medicines (trametinib or cetuximab). Researchers monitored…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC